Showing 1 posts of 1 posts found.
Kither Biotech has reported positive results from a phase 1 study of KIT2014, an investigational inhaled therapy being developed for …
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation